Exponent (US.EXPO)
Capital Allocation Audit · Period: 2010 – 2026
Key Metrics
US.EXPO · YoY: 2026 H1 vs 2025 H1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | - | → |
| ROE | 20.4% | ↑ |
| Cash Conversion | 0.0% | ↓ |
| D/E Ratio | 0.28 | ↓ |
| Gross Margin | 0.0% | ↓ |
US.EXPO (Exponent) | YoY: 2026 H1 vs 2025 H1 Metric Value YoY --------------------------- FCF Conversion - → ROE 20.4% ↑ Cash Conversion 0.0% ↓ D/E Ratio 0.28 ↓ Gross Margin 0.0% ↓
Key Metrics
US.EXPO (Exponent) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY---------------------------FCF Conversion - →ROE 20.4% ↑Cash Conversion 0.0% ↓D/E Ratio 0.28 ↓Gross Margin 0.0% ↓Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies